A new cancer therapy at Providence helps immune cells stand their ground
A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.
Read Article
-
-
A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.
Read Article
-
Cancer patients in Newberg receive a gift of comfort
A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.
Read Article
-
New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research
Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.
Read Article
-
Providence researchers share cancer discoveries at 2025 ASCO meeting
Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.
Read Article
-
Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence
Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.
Read Article
-
Clinical trials matter, just ask Randy
When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.
Read Article
-
Studies to be presented by Providence researchers at AACR annual meeting
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.
Read Article
-
How cold cap therapy prevented patient’s hair loss during cancer treatment
What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.
Read Article
-
Seeking better treatments for people with ER+/HER- breast cancer
Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.
Read Article
-
From life-saving surgery to back on the slopes: A photographer’s story
Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.
Read Article
-
Robotic versus open surgery for early cervical cancer
This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.
Read Article
-
A year to remember: Advancements, recognition and transitions
Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
Read Article
-
CAR T cell-therapy, hope and healing: Dean’s story
Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.
Read Article
-
Two clinical trials for solid tumor cancers take different approaches to stop growth
Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.
Read Article
-
Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
Read Article
-
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
Read Article
-
New studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
Read Article
-
Attend a free virtual symposium on melanoma, Oct. 25
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
Read Article
-
Prostate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
Read Article
-
Loading More...
